These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
419 related articles for article (PubMed ID: 16361543)
1. Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma. Aghi M; Gaviani P; Henson JW; Batchelor TT; Louis DN; Barker FG Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8600-5. PubMed ID: 16361543 [TBL] [Abstract][Full Text] [Related]
2. Selection pressures of TP53 mutation and microenvironmental location influence epidermal growth factor receptor gene amplification in human glioblastomas. Okada Y; Hurwitz EE; Esposito JM; Brower MA; Nutt CL; Louis DN Cancer Res; 2003 Jan; 63(2):413-6. PubMed ID: 12543796 [TBL] [Abstract][Full Text] [Related]
3. Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival. Eoli M; Menghi F; Bruzzone MG; De Simone T; Valletta L; Pollo B; Bissola L; Silvani A; Bianchessi D; D'Incerti L; Filippini G; Broggi G; Boiardi A; Finocchiaro G Clin Cancer Res; 2007 May; 13(9):2606-13. PubMed ID: 17473190 [TBL] [Abstract][Full Text] [Related]
4. Amplification of the epidermal growth factor receptor gene in glioblastoma: an analysis of the relationship between genotype and phenotype by CISH method. Miyanaga T; Hirato J; Nakazato Y Neuropathology; 2008 Apr; 28(2):116-26. PubMed ID: 18021194 [TBL] [Abstract][Full Text] [Related]
5. Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas. Frederick L; Wang XY; Eley G; James CD Cancer Res; 2000 Mar; 60(5):1383-7. PubMed ID: 10728703 [TBL] [Abstract][Full Text] [Related]
6. Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas. Sure U; Rüedi D; Tachibana O; Yonekawa Y; Ohgaki H; Kleihues P; Hegi ME J Neuropathol Exp Neurol; 1997 Jul; 56(7):782-9. PubMed ID: 9210874 [TBL] [Abstract][Full Text] [Related]
7. Correlation among pathology, genotype, and patient outcomes in glioblastoma. Homma T; Fukushima T; Vaccarella S; Yonekawa Y; Di Patre PL; Franceschi S; Ohgaki H J Neuropathol Exp Neurol; 2006 Sep; 65(9):846-54. PubMed ID: 16957578 [TBL] [Abstract][Full Text] [Related]
8. Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme. Joensuu H; Puputti M; Sihto H; Tynninen O; Nupponen NN J Pathol; 2005 Oct; 207(2):224-31. PubMed ID: 16021678 [TBL] [Abstract][Full Text] [Related]
9. Molecular genetic analysis of deep-seated glioblastomas. Hayashi Y; Yamashita J; Watanabe T Cancer Genet Cytogenet; 2004 Aug; 153(1):64-8. PubMed ID: 15325097 [TBL] [Abstract][Full Text] [Related]
10. Genetic analyses for predictors of radiation response in glioblastoma. Shih HA; Betensky RA; Dorfman MV; Louis DN; Loeffler JS; Batchelor TT Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):704-10. PubMed ID: 15978739 [TBL] [Abstract][Full Text] [Related]
11. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype. Choe G; Park JK; Jouben-Steele L; Kremen TJ; Liau LM; Vinters HV; Cloughesy TF; Mischel PS Clin Cancer Res; 2002 Sep; 8(9):2894-901. PubMed ID: 12231534 [TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme. Quan AL; Barnett GH; Lee SY; Vogelbaum MA; Toms SA; Staugaitis SM; Prayson RA; Peereboom DM; Stevens GH; Cohen BH; Suh JH Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):695-703. PubMed ID: 15936158 [TBL] [Abstract][Full Text] [Related]
13. Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Fleming TP; Saxena A; Clark WC; Robertson JT; Oldfield EH; Aaronson SA; Ali IU Cancer Res; 1992 Aug; 52(16):4550-3. PubMed ID: 1322795 [TBL] [Abstract][Full Text] [Related]
16. Two independent amplification events on chromosome 7 in glioma: amplification of the epidermal growth factor receptor gene and amplification of the oncogene MET. Wullich B; Sattler HP; Fischer U; Meese E Anticancer Res; 1994; 14(2A):577-9. PubMed ID: 8017863 [TBL] [Abstract][Full Text] [Related]
17. The infrequent simultaneous genetic alterations in glioblastoma multiforme (LOH 10, 17, 19q, TP53 mutation and EGFR amplification) with short clinical course. Jesionek-Kupnicka D; Kulczycka D; Rieske P; Szybka M; Jabłońska J; Potemski P; Kolasa P; Liberski PP; Kordek R Pol J Pathol; 2007; 58(2):79-85. PubMed ID: 17715673 [TBL] [Abstract][Full Text] [Related]
18. Amplification of the epidermal growth factor receptor in astrocytic tumours by chromogenic in situ hybridization: association with clinicopathological features and patient survival. Järvelä S; Helin H; Haapasalo J; Järvelä T; Junttila TT; Elenius K; Tanner M; Haapasalo H; Isola J Neuropathol Appl Neurobiol; 2006 Aug; 32(4):441-50. PubMed ID: 16866989 [TBL] [Abstract][Full Text] [Related]
19. Altered expression of the suppressors PML and p53 in glioblastoma cells with the antisense-EGF-receptor. Tian XX; Chan JY; Pang JC; Chen J; He JH; To TS; Leung SF; Ng HK Br J Cancer; 1999 Nov; 81(6):994-1001. PubMed ID: 10576656 [TBL] [Abstract][Full Text] [Related]
20. Utility of chromogenic in situ hybridization (CISH) for detection of EGFR amplification in glioblastoma: comparison with fluorescence in situ hybridization (FISH). Fischer I; de la Cruz C; Rivera AL; Aldape K Diagn Mol Pathol; 2008 Dec; 17(4):227-30. PubMed ID: 18382350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]